Corbus Pharmaceuticals Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Norwood, MA USA
Total Funding:$64M
Industry:Cannabis
Founded:2009
Lead Investor(s):Aegis Capital Corp

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Corbus Pharmaceuticals's estimated annual revenue is currently $4.8M per year.
  • Corbus Pharmaceuticals received $27.2M in venture funding in March 2017.
  • Corbus Pharmaceuticals's estimated revenue per employee is $31,299
  • Corbus Pharmaceuticals's total funding is $64M.

Employee Data

  • Corbus Pharmaceuticals has 154 Employees.
  • Corbus Pharmaceuticals grew their employee count by 19% last year.
  • Corbus Pharmaceuticals currently has 21 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
MCR Labs
$21.6M8086%N/AN/A
Theory Wellness...
$12.7M477%N/AN/A
Davis Malm
$24.3M900%N/AN/A
TILT Holdings
$11.1M41-36%N/AN/A
Cannabis Contro...
$11.1M41128%N/AN/A
Temescal Wellne...
$14M526%N/AN/A
Calyx Container...
$11.1M4164%N/AN/A
Sira Naturals
$30.5M11353%N/AN/A
Phase Zero Desi...
$14M526%N/AN/A
INSA
$37.8M1401%N/AN/A
Missing a competitor? Contribute!?
Submit

Corbus Pharmaceuticals (NASDAQ: CRBP) is a Phase 3, clinical-stage pharmaceutical company focused on advancing the development and commercialization of novel therapies to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Corbus Pharma was named one of the Best Places To Work by Boston Business Journal in 2017. Our people are high-achievers, innovative, creative and, above all else, passionate about what we do in systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus eythematosus.

keywords:Biotechnology,Healthcare,Pharmaceuticals

154

Number of Employees

$4.8M

Revenue (est)

21

Current Jobs

19%

Employee Growth %

$64M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Yuval CohenChief Executive Officer, DirectorEmail Available
Mark TepperPresident/Chief Scientific OfficerEmail Available
Sean MoranChief Financial OfficerEmail Available
Charity ConnerDirector Data Management
Jungeun LeeAccounting Manager
Barbara WhiteChief Medical OfficerEmail Available
Robert DiscordiaChief Operating OfficerEmail Available
Caitlin CornwallClinical Trial Manager, Rare Disease
Timothy ThullenDirector, Toxicology
Erika MolignanoDirector Of Quality Assurance

Corbus Pharmaceuticals News

09/09/2019 - Can Corbus Pharmaceuticals Holdings, Inc. (CRBP) Continue ...

Corbus Pharmaceuticals Holdings, Inc. (CRBP) shares are showing positive signals short-term as the stock has finished higher by 3.22% for ...

08/14/2019 - Have Insiders Been Buying Corbus Pharmaceuticals Holdings ...

So we'll take a look at whether insiders have been buying or selling shares in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP).

08/12/2019 - Update: Corbus Pharmaceuticals Holdings (NASDAQ:CRBP ...

While Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) shareholders are probably generally happy, the stock hasn't had particularly ...

Corbus Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2014-04-29$6.3MUndisclosedArticle
2014-06-04$10.3MUndisclosedAegis Capital CorpArticle
2014-12-12$12.7MUndisclosedArticle
2016-06-13$14.9MUndisclosedArticle
2017-03-01$27.2MUndisclosedArticle